Ascendis Pharma Receives Positive CHMP Opinion for TransCon™ PTH (palopegteriparatide) for Adults with Chronic Hypoparathyroidism

Источник: Nasdaq GlobeNewswire / 14 сен 2023 12:22:57   America/New_York